Partner with Duke in Clinical Research

Davison Building in Autumn foliage

Partner with Duke’s World-Class Research Enterprise

Duke University School of Medicine offers a collaborative environment for industry sponsors seeking excellence in clinical research. Our experienced faculty, advanced infrastructure, and streamlined startup processes make Duke an ideal partner for innovation in medicine.

Why Partner With Duke

Faculty Expertise

Duke SOM supports more than 2,600 basic and clinical faculty across 40 departments, centers, and initiatives — making it one of the largest biomedical research enterprises in the United States. With over $1 billion in sponsored research expenditures annually, Duke brings scale and sophistication to clinical research programs. Whether planning early-phase investigational trials or large multi-site pivotal studies, our infrastructure — from dedicated clinical research sites to integrated health-system data and analytics — positions you to execute with excellence.

Picture of mural

World-Class Facilities & Infrastructure 

Duke provides industry partners with access to cutting-edge research and clinical infrastructure, including more than 70 shared service centers in genomics, proteomics, and informatics. Our flagship hospital and dedicated early-phase research unit (DEPRU) support complex clinical trials from Phase I through Phase IV. With over 1,100 DCRI network sites nationwide and purpose-built facilities like Duke Research & Discovery @ RTP, we combine scale, sophistication, and efficiency to accelerate study startup and execution.

Rapid Study Startup

Duke’s contracting, regulatory, and operational teams are structured to help industry partners move quickly from concept to activation.

  • One master contract provides access to multiple sites

  • Streamlined IRB and regulatory pathways

  • Dedicated industry engagement and startup specialists

Our proven processes help you initiate trials faster — without compromising quality or compliance.